Human papillomavirus vaccination in tanzanian schoolgirls: Cluster-randomized trial comparing 2 vaccine-delivery strategies

Journal of Infectious Diseases

Volumn 206, Issue 5, 2012, Pages 678-686

  Watson Jones, Deborah ^a,c   Baisley, Kathy ^a   Ponsiano, Riziki ^c   Lemme, Francesca ^a,c   Remes, Pieter ^b,c   Ross, David ^a   Kapiga, Saidi ^a,c   Mayaud, Philippe ^a   De Sanjosé, Silvia ^e,f   Wight, Daniel ^b   Changalucha, John ^d   Hayes, Richard ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b MEDICAL RESEARCH COUNCIL   (United Kingdom)

^c National Institute for Medical Research   (Tanzania)

^d NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (Tanzania)

^e CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^f CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

WART VIRUS VACCINE;

ABSENTEEISM; ADOLESCENT; AGE; ARTICLE; CHEST INFECTION; CHILD; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG ERUPTION; DRUG INDUCED HEADACHE; FATIGUE; FEMALE; HUMAN; MALARIA; OUTCOME ASSESSMENT; PAPILLOMAVIRUS INFECTION; PHASE 4 CLINICAL TRIAL; PRIMARY SCHOOL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RURAL AREA; SCHOOL CHILD; TANZANIA; TREATMENT REFUSAL; URBAN AREA; VACCINATION;

ADOLESCENT; CHILD; CLUSTER ANALYSIS; FEMALE; HUMANS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; RURAL POPULATION; TANZANIA; URBAN POPULATION; VACCINATION;

EID: 84864002844     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jis407     Document Type: Article

References (29)

1. Koutsky L. Epidemiology of genital human papillomavirus infection. Am J Med 1997; 102:3-8. (Pubitemid 127695953)
2. Walbloomers JM, Jacobs MV, Manos MM, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999; 189:12-9. (Pubitemid 29406813)
3. Yang BH, Bray FI, Parkin DM, Sellors JW, Zhang ZF. Cervical cancer as a priority for prevention in different world regions: an evaluation using years of life lost. Int J Cancer 2004; 109:418-24. (Pubitemid 38252771)
4. Ferlay JSH, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010; 127:2893-917.
5. GAVI Alliance. GAVI investment strategy. Human papillomavirus analysis, 2008 http://www.gavialliance.org/search/?SearchFor=0SearchText= Landscape+analysis+HPV. Accessed 3 February 2012.
6. Sankaranarayanan R, Black RJ, Parkin DM. Cancer survival in developing countries. IARC Scientific Publications no. 145. Lyon: International Agency for Research on Cancer, 1998.
7. Paavonen J, Naud P, Salmeron J, et al. Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomized study in young women. Lancet 2009; 374:301-14.
8. Future I/II Study Group; Dillner J, Kjaer SK, et al. Four year efficacy of prophylactic human papillomavirus quadrivalent vaccine against low grade cervical, vulvar, and vaginal intraepithelial neoplasia and anogenital warts: randomized controlled trial. BMJ 2010; 341: c3493.
9. Reeve C, De La Rue S, Pashen D, Culpan M, Cheffins T. School-based vaccinations delivered by general practice in rural north Queensland: an evaluation of a new human papilloma virus vaccination program. Commun Dis Intell 2008; 32:94-8.
10. Remes P, Selestine V, Soteli S, et al. Is HPV vaccination in primary schools acceptable in Tanzanian communities [abstract O-09.07]. In: Program and abstracts of the 27th International Human Papillomavirus Conference, Berlin, Germany, 17-22 September 2011.
11. Zaba B, Isingo R, Wringe A, Marston M, Slaymaker E, Urassa M. Influence of timing of sexual debut and first marriage on sexual behaviour in later life: findings from four survey rounds in the Kisesa cohort in northern Tanzania. Sex Transm Infect 2009; 85(Suppl 1): i20-6.
12. Tanzania Demographic and Health Survey 2010. National Bureau of Statistics, Dar es Salaam. April 2011. http://www.measuredhs.com/pubs/pdf/FR243/ FR243[24June2011].pdf. Accessed 3 February 2012.
13. PATH. Child Health and Development Centre (CHDC), and the Uganda National Expanded Program on Immunization (UNEPI). HPV vaccination in Africa: lessons learned from a pilot program in Uganda. Seattle: PATH, 2011. http://www.rho.org/files/PATH-HPV-lessons-learned-Uganda-2011.pdf. Accessed 14 December 2011.
14. LaMontagne DS, Jacob M, Ramos I, Mugisha E, Le NT. Delivery strategies for human papillomavirus vaccinations that achieve high coverage in developing countries [abstract P-712]. In: Program and abstracts of the 26th International Papillomavirus Conference, Montreal, Canada, 3-8 July 2010.
15. Department of Health & Health Protection Agency. Annual HPV vaccine coverage in England in 2009/2010. http://www.dh.gov.uk/prod-consum-dh/groups/dh- digitalassets/documents/digitalasset/dh-123826.pdf. Accessed 14 December 2011.
16. LaMontagne DS, Barge S, Le NT, et al. Human papillomavirus vaccine delivery strategies that achieved high coverage in low-and middleincome countries. Bull World Health Organ 2011; 89:821-30B.
17. Stokley S, Cohn A, Jain N, McCauley MM. Compliance with recommendations and opportunities for vaccination at ages 11 to 12 years: evaluation of the 2009 national immunization survey-teen. Arch Pediatr Adolesc Med 2011; 165:813-8.
18. National and state vaccination coverage among adolescents aged 13 through 17 years-United States, 2010. MMWR Morb Mortal Wkly Rep 2011; 60:1117-23.
19. European Cervical Cancer Association. HPV vaccination across Europe. http://www.ecca.info/fileadmin/user-upload/HPV-Vaccination/ECCA-HPV-Vaccination- April-2009.pdf. Accessed 14 December 2011.
20. Zimet GD, Weiss TW, Rosenthal SL, Good MB, Vichnin MD. Reasons for non-vaccination against HPV and future vaccination intentions among 19-26 year-old women. BMC Womens Health 2010; 10:27.
21. Dorleans F, Giambi C, Dematte L, et al. The current state of introduction of human papillomavirus vaccination into national immunisation schedules in Europe: first results of the VENICE2 2010 survey. Euro Surveill 2010; 15:pii = 19730. http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19730. Accessed 14 December 2011.
22. Seruyange R. Child Days Plus-the Uganda experience. Paper presented at: Introduction of new vaccines-Experience Exchange Meeting, Pretoria, 28-30 July 2010.
23. Mugyenyi P, Mbabazi W, Kabwongera E. Child Days Plus in Uganda: best practices and challenges. Paper presented at: Global Immunization Meeting, New York, 17-19 February 2009. http://www.who.int/immunization/newsroom/190209-P- Mugyenyi.pdf. Accessed 12 November 2011.
24. Mwandoloma H. Vaccination campaign ends amid reservations. The Guardian. 2 September 2008.
25. Basic statistics in education: 1994-1998. Ministry of Education and Culture, Dar es Salaam: United Republic of Tanzania, 1999.
26. UNICEF. Tanzania, United Republic of: statistics. http://www.unicef. org/infobycountry/tanzania-statistics.html. Accessed 2 February 2012.
27. Quentin W, Watson-Jones D, Changalucha J, et al. Costs of delivering HPV vaccine to school girls in Tanzania [abstract O 05.05]. Paper presented at: 27th International Papillomavirus Conference, Berlin, 17-22 September 2011. In: Program and abstracts of the 27th International Papillomavirus Conference (Berlin), Germany, 2011, 17-22 Septembe.r.
28. Basic Education Statistics in Tanzania (BEST). 2010 Regional Data. Ministry of Education and Vocational Training, Dar es Salaam, United Republic of Tanzania, December, 2010. http://216.15.191.173/statistics.html. Accessed 3 February 2012.
29. Watson-Jones D, Brown J, De Sanjosé S, et al. Cervical HPV prevalence and genotypes in Tanzanian girls and women [abstract P-02.24]. In: Program and abstracts of the 27th International Papillomavirus Conference, Berlin, Germany, 17-22 September 2011.